Table A : GLP-1RAs versus other glucose-lowering agents: key specific features that impact treatment choice Given that there are few head-to-head studies comparing glucose-lowering effects between different drug classes, and the difficulty involved in performing cross-study comparisons due to different patient characteristics and baseline HbA 1c levels, there is widespread consensus that GLP-1RAs are more efficacious at lowering blood glucose than either DPP-IVs or SGLT-2 inhibitors
For Canadian researchers investigating peptide protocols for metabolic health, this combination presents a multi-pronged approach: one compound handles caloric balance and total weight, while the other fine-tunes body composition and metabolic markers
Acetyl-L-carnitine facilitates the movement of fatty acids into mitochondria, where they can be burned as fuel to produce energy
Pairing it with a small carbohydrate source, like a banana or oats, can improve absorption and energy availability
Tirzepatide is already FDA-approved for diabetes (sold as Mounjaro), as well as for weight loss and now sleep apnea (sold as Zepbound)
If you dont have insurance or have limited coverage and have type 2 diabetes, you might be able to get Victoza for free through the Novo Nordisk patient assistance program if you meet certain income and insurance criteria